• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙拮抗剂维拉帕米的半刚性类似物:一项分子建模研究。

Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.

作者信息

Romanelli M N, Dei S, Scapecchi S, Teodori E, Gualtieri F, Budriesi R, Mannhold R

机构信息

Dipartimento di Scienze Farmaceutiche, Università di Firenze, Italy.

出版信息

J Comput Aided Mol Des. 1994 Apr;8(2):123-34. doi: 10.1007/BF00119863.

DOI:10.1007/BF00119863
PMID:8064330
Abstract

In this work the rigid-analogue approach has been used to obtain information on the active conformation(s) of the calcium antagonist verapamil. A series of semi-rigid analogues of verapamil were synthesized and their biological activities evaluated on guinea-pig heart and aorta. These molecules were analysed by means of molecular modelling techniques. On the basis of the pharmacological profile and conformational analysis of these compounds, two different models for negative inotropic and negative chronotropic activity are proposed. The two actions seem to be due to conformations of the molecules which differ in the orientation of their phenylethylamino groups.

摘要

在这项研究中,采用刚性类似物方法来获取钙拮抗剂维拉帕米活性构象的信息。合成了一系列维拉帕米的半刚性类似物,并在豚鼠心脏和主动脉上评估了它们的生物活性。借助分子建模技术对这些分子进行了分析。基于这些化合物的药理学特征和构象分析,提出了两种不同的负性肌力和负性变时活性模型。这两种作用似乎是由于分子构象不同,其苯乙胺基的取向也不同。

相似文献

1
Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.钙拮抗剂维拉帕米的半刚性类似物:一项分子建模研究。
J Comput Aided Mol Des. 1994 Apr;8(2):123-34. doi: 10.1007/BF00119863.
2
Synthesis and cardiovascular properties of fluorenyl derivatives related to verapamil.与维拉帕米相关的芴基衍生物的合成及心血管特性
Farmaco. 1991 Oct;46(10):1121-38.
3
Verapamil analogues with restricted molecular flexibility: synthesis and pharmacological evaluation of the four isomers of alpha-[1-[3-[N-[1- [2-(3,4-dimethoxyphenyl)ethyl]]-N-methylamino]cyclohexyl]]-alpha- isopropyl-3,4-dimethoxybenzene-acetonitrile.具有受限分子柔性的维拉帕米类似物:α-[1-[3-[N-[1-[2-(3,4-二甲氧基苯基)乙基]]-N-甲基氨基]环己基]]-α-异丙基-3,4-二甲氧基苯乙腈四种异构体的合成与药理评价
J Med Chem. 1993 Feb 19;36(4):439-45. doi: 10.1021/jm00056a003.
4
A search for calcium-channel activators in the verapamil series.对维拉帕米系列中钙通道激活剂的研究。
Farmaco. 1989 May;44(5):449-64. doi: 10.1002/chin.198952109.
5
Verapamil analogues with restricted molecular flexibility.具有受限分子柔韧性的维拉帕米类似物。
J Med Chem. 1991 Jul;34(7):2219-25. doi: 10.1021/jm00111a043.
6
Comparative determination of the cardioselectivity of taxine and verapamil in the isolated aorta, atrium and jejunum preparations of rabbits.兔离体主动脉、心房和空肠标本中紫杉醇与维拉帕米心脏选择性的比较测定
Arzneimittelforschung. 1999 Aug;49(8):673-8. doi: 10.1055/s-0031-1300481.
7
Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.新型钙拮抗剂富马酸芝麻二酯在离体平滑肌和心肌中的组织选择性
Arzneimittelforschung. 1990 Mar;40(3):244-8.
8
Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.与硝苯地平、维拉帕米和地尔硫䓬相比,依福地平在体外对心肌和血管的作用。
Gen Pharmacol. 1996 Apr;27(3):451-4. doi: 10.1016/0306-3623(95)02065-9.
9
SAR studies in the field of calcium(II) antagonists. Effect of modifications at the tetrasubstituted carbon of verapamil-like compounds.钙(II)拮抗剂领域的构效关系研究。维拉帕米类化合物四取代碳上修饰的影响。
J Med Chem. 1985 Nov;28(11):1621-8. doi: 10.1021/jm00149a014.
10
Coumarin 1,4-dihydropyridine derivatives.香豆素 1,4 - 二氢吡啶衍生物
Bioorg Med Chem. 1998 Jun;6(6):803-10. doi: 10.1016/s0968-0896(98)00037-6.

本文引用的文献

1
Verapamil analogues with restricted molecular flexibility: synthesis and pharmacological evaluation of the four isomers of alpha-[1-[3-[N-[1- [2-(3,4-dimethoxyphenyl)ethyl]]-N-methylamino]cyclohexyl]]-alpha- isopropyl-3,4-dimethoxybenzene-acetonitrile.具有受限分子柔性的维拉帕米类似物:α-[1-[3-[N-[1-[2-(3,4-二甲氧基苯基)乙基]]-N-甲基氨基]环己基]]-α-异丙基-3,4-二甲氧基苯乙腈四种异构体的合成与药理评价
J Med Chem. 1993 Feb 19;36(4):439-45. doi: 10.1021/jm00056a003.
2
Conformationally restricted congeners of dopamine derived from 2-aminoindan.源自2-氨基茚满的多巴胺构象受限类似物。
J Med Chem. 1982 Dec;25(12):1442-6. doi: 10.1021/jm00354a010.
3
Ionization and surface properties of verapamil and several verapamil analogues.
维拉帕米及几种维拉帕米类似物的电离作用和表面性质。
J Pharm Sci. 1986 Oct;75(10):976-82. doi: 10.1002/jps.2600751014.
4
Evidence that uncharged verapamil inhibits myocardial contractility.
J Pharmacol Exp Ther. 1987 Aug;242(2):721-5.
5
Comparative QSAR studies on vasodilatory and negative inotropic properties of ring-varied verapamil congeners.环结构各异的维拉帕米类似物的血管舒张和负性肌力特性的比较定量构效关系研究
Arzneimittelforschung. 1987 Apr;37(4):419-24.
6
6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent.6-甲基-6-氮杂双环[3.2.1]辛烷-3α-醇2,2-二苯基丙酸酯(阿扎丙醇),一种高效的抗毒蕈碱剂。
J Med Chem. 1987 May;30(5):805-9. doi: 10.1021/jm00388a010.
7
Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart.猫心脏中1,4 - 二氢吡啶和苯烷基胺类钙通道阻滞剂的负性肌力作用强度与结合参数之间的相关性
Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):303-12. doi: 10.1007/BF00508786.
8
Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
Farmaco. 1989 Dec;44(12):1167-91.
9
A search for calcium-channel activators in the verapamil series.对维拉帕米系列中钙通道激活剂的研究。
Farmaco. 1989 May;44(5):449-64. doi: 10.1002/chin.198952109.
10
Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic properties.特定的心动过缓药物。1. 取代苯并氮杂䓬酮的化学、药理学及构效关系,一类具有抗缺血特性的新型化合物。
J Med Chem. 1990 May;33(5):1496-504. doi: 10.1021/jm00167a033.